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Abstract
The aim of this project was the development of an alkyne-functionalized
fourth generation polyester dendron, based on 2,2-bis(hydroxymethyl)pro-
pionic acid (bis-MPA), according to a double-stage convergent growth ap-
proach. The different architectures were characterized by nuclear magnetic
resonance (NMR) spectroscopy and matrix-assisted laser desorption ioniza-
tion time-of-flight mass spectrometry (MALDI-TOF-MS).
The [G-4] dendron attained, with a carboxylic group in its core, was sub-
jected to several alkyne functionalization reactions that were not effective.
In this sense, a novel route to construct the polyester dendron was car-
ried out, via carboxylic anhydride, and an alkyne-functionalized [G-2] den-
dron was successfully synthesized. To construct a [G-4] dendron, esterifica-
tion and acylation reactions were performed, but the results suggested that
alkyne terminal was affected.
Simultaneoulsy, alkyne functionalization reactions of poly(ethylene gly-
col) (PEG) were also carried out, and after several attempts, the objective
was accomplished.
Although the initial purpose have not been fully achieved, the method-
ologies discussed and the results obtained in this study allow us to under-
stand the chemistry behind the synthesis of dendrons. This knowledge is
of utmost importance to define the future directions of the projects in this
area.
Keywords: anhydride, bis-MPA, dendron, PEG

Resumo
Este projecto teve como principal objectivo o desenvolvimento de uma
estrutura dendr´ıtica de quarta gerac¸a˜o, de base polie´ster, funcionalizada com
um grupo alcino.
O dendron de quarta gerac¸a˜o (baseada no composto bis-MPA) foi sinteti-
zado segundo o me´todo double-stage convergent growth, tendo os resultados
obtidos sido confirmados por ressonaˆncia magne´tica nuclear e espectrome-
tria de massa. A estrutura sintetizada, com um grupo carbox´ılico no seu
‘nu´cleo’, foi sujeita a diversas reacc¸o˜es de funcionalizac¸a˜o com terminais
alcino, revelando-se, no entanto, infrut´ıferas.
Deste modo, um novo me´todo, atrave´s do anidrido carbox´ılico, foi tes-
tado e um dendron de segunda gerac¸a˜o, funcionalizado com o grupo alcino,
foi sintetizado com sucesso. Com o mesmo intuito de construir uma estrutura
de quarta gerac¸a˜o, reacc¸o˜es de esterificac¸a˜o e acilac¸a˜o foram executadas, mas
os resultados obtidos sugerem que o terminal alcino, presente inicialmente,
foi afectado.
Concomitantemente, reacc¸o˜es de funcionalizac¸a˜o do polietilenoglicol com
um terminal alcino foram tambe´m realizadas, tendo sido sintetizado com
sucesso (apo´s va´rias tentativas).
Embora o objectivo inicial na˜o tenho sido totalmente alcanc¸ado, as meto-
dologias abordadas e os resultados obtidos neste projecto, permitem retirar
algumas ilac¸o˜es acerca do processo de s´ıntese de estruturas dendr´ıticas. Este
conhecimento reveste-se de especial importaˆncia na definic¸a˜o de novas es-
trate´gias que devem ser adoptadas futuramente.
Palavras-chave: anidrido, bis-MPA, PEG
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1Introduction
Cancer is one of the most challenging medical problems faced by science
today. According to the International Agency for Research on Cancer, in
2008, around 12.7 million new cases were registered and the total cost of
treatment amounted to over 890 billion dollars7.
Therefore, improving our knowledge of cancer pathophysiology, discovering
new anticancer drugs and developing novel biomedical technologies are of
utmost importance nowadays.
New developments in targeted drug delivery methods can be a promising
alternative: dendrimers are a class of nanoparticles that are being explored
in this sense.
The aim of this project included initially five main tasks:
1. Task I
. The synthesis of an alkyne-functionalized [G-4] aliphatic polyester
dendron based on bis-MPA, using a double-stage convergent growth
approach;
2. Task II
. The covalent attachment of a stimuli-responsive linear polymer
prepared by ‘controlled’/living radical polymerization, using a
‘click’ chemistry approach;
3. Task III
. The assess of the self-assembly behaviour of the amphiphilic linear-
dendritic block copolymer prepared, under different pH and tem-
perature conditions;
1
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4. Task IV
. Alkyne functionalization of poly(ethylene glycol) methyl ether
(Mn∼ 2000) and synthesis of linear-linear block copolymer through
‘click’ chemistry;
5. Task V
. Self-assembly studies of the amphiphilic linear-linear block copoly-
mers.
Unfortunately, the initial plan was too ambitious due to the several dif-
ficulties encountered during the accomplishment of the first task. For this
reason, tasks II, III and V weren’t performed.
Therefore, in the present work, we intend to describe and discuss the
several synthesis methodologies carried out - double-stage convergent growth
and anhydride route - to attain the fourth generation polyester monodendron
with the final core functionalized by an alkyne moiety.
At the same time, poly(ethylene glycol) methyl ether alkyne functional-
ization reactions are also discussed as well as ‘click’ reactions attempts.
The general proceedings of the present work are chronologically repre-
sented in the timetable from Figure 1.1.
Figure 1.1: Condensed timetable of project proceedings.
In the second chapter of this dissertation, it will be highlighted the main
properties of drug delivery systems and how they can be applied in medi-
cal and pharmaceutical fields. Furthermore, it will be made a brief review
about the state of art of dendritic polymers and stimuli-responsive polymers.
Structural characteristics of linear-dendritic block copolymers, their synthe-
sis methodologies and some biocompatibility aspects will be also discussed.
2
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In the third chapter, the different synthesis methodologies performed
will be described. The materials as well as the characterization techniques
used in order to characterize the synthetic structures will be presented.
In the fourth and fifth chapters, the experimental results will be com-
pared and discussed. Finally, overall conclusions and guidelines for future
work in this field will be suggested.
3

2Theoretical Background
2.1 Drug delivery systems
Often, we imagine that our body can be mended and improved through
the addition of chemicals, but we don’t really understand the identity of all
of them in the system, the forces that hold them together or the network of
interactions that mold the chemicals into the organism. This is the challenge
of drug delivery.
There are several forms of drug administration such as pills, injections,
suppositories, and all of them have been already experimented by most
people.
These conventional drug delivery methods result in a peak in plasma
drug concentrations, followed by a plateau and finally a decline. As a re-
sult, these common formulations require a high concentration of the drug
at the time of the release, but only a small dose reaches the desired loca-
tion. Therefore, it is necessary the administration of higher dosages than
required to achieve the desired therapeutic effect, which may lead to toxic
plasma drug concentrations or ineffective plasma levels8. Although these
systems maintain the drug within the desired therapeutic range with just a
single dose, they remain insensitive to the changing metabolic states of the
body.
In this sense, mechanisms capable of responding to these physiological
variations must be provided in order to synchronize drug-release profiles
with changing physiological conditions.
Controlled drug delivery systems (DDS) allow gradual and prolonged
release of the active compound in a specific tissue, maximizing the thera-
peutic index and reducing the adverse effects. Ideally, they should respond
to physiological requirements, sense the changes and alter the drug-release
profile accordingly9.
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Their biggest advantages are depicted in Figure 2.1: reduction of dosing
frequency, controlled release rate of drug during a pre-defined time period
and maximization of therapeutic index to avoid an overdose or underdose1.
Figure 2.1: Patterns of drug concentration after administration by conven-
tional methods (e.g., single dose and several doses) and by controlled drug
delivery systems (adapted from1).
The different pathophysiological conditions of diseases continually call
for innovative therapeutic approaches. The development of polymeric DDS
is always dependent on a thorough knowledge of physical, chemical, mor-
phological and biological properties of the polymer and therapeutic agent.
The versatility of polymeric materials allow us to design innovative sys-
tems with distinct characteristics at structural and functional levels, through
the tailor of molecular weight, addition of bioresponsive elements, control of
the size, shape, composition, chemical functionality and self-assembly pro-
cess10.
Throughout the development process, it is necessary to address all the
biological safety requirements of a drug-polymer carrier: they should be
water soluble, biocompatible, biodegradable and bioactive11. Besides, DDS
should also address the following criteria: high drug loading capacity, ade-
quate binding affinity and stability in the blood stream, long time circulation
properties, suitable release kinetics along with selective bioactive agent dis-
tribution pattern10.
Fast degradation, unfavorable distribution, elimination by glomerular
filtration and side effects are problems that drug administration face. So,
when designing drug delivery carriers for biomedical applications, there are
numerous aspects to be consider such as prolong circulation half-time of the
drug, promote target delivery, maximize drug bioavailability, minimize side
effects and improve therapeutic efficacy.
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Control key aspects of biodistribution and cellular internalization is ex-
tremely important. The development of molecular nanostructures with well
defined shape and size is of eminent interest in medical field for the delivery
of active pharmaceuticals agents11.
2.2 Therapeutic applications
Cancer
In the past years, therapeutic agents used in conventional chemotherapy
are plagued by lack of selectivity associated with low therapeutic index. In
this sense, tumour-targeting DDS offer themselves as an alternative.
The primary goal of these approaches relies on the accumulation of engi-
neered nanoparticles in solid tumour tissue due to the enhanced permeability
and retention (EPR) effect12.
In contrast with healthy tissue, the fast development of vasculature in
tumour tissue, by abnormal angiogenesis, lead to an hyperpermeability of
the endothelial cells owing to the inherent pores in the vessel walls (with an
average size of ∼ 400 nm). These intercellular gaps in tumour vasculature
allow nanoparticles to escape from the circulation and to extravasate into
the tumour (passive targeting). Moreover, the lack of lymphatic drainage
lead to the accumulation of macromolecular drugs in the interstitium of
tumours13.
To capitalize on the EPR effect, a high concentration of the drug in the
systemic circulation as a function of time should be achieved to maximize dif-
fusion out of the leaky blood vessels into tumour tissue. The encapsulation
of an active agent confer enhanced solubility, cellular uptake, intestinal ab-
sorption and physical stability. Thus, a prolonged circulation and improved
tumour accumulation of the drug is attained, enhancing anti-tumour efficacy
(compared with the free drug) and increasing the therapeutic window13. Be-
sides, the polymer molecular weight of the polymer-drug conjugate can be
tuned to take advantage of this effect.
One of the crucial points in this process is the efficiency of the carrier to
release the drug in the target tissue, ideally, few minutes after their inter-
nalization through the mechanism of endocytosis. The acidic media of the
endossome act as a trigger: dissociate the nanocarrier and release the drug.
The size of the nanoparticles is an important factor in controlling the
biodistribution of the drug in the human body; it influences particle uptake,
deposition and clearance. Drug carriers should have a diameter larger than
3 nm to prevent rapid clearance by the kidneys but smaller than 200 nm to
avoid the reticuloendothelial system (RES) (ideally ∼ 10− 100 nm)14.
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Figure 2.2: Schematic of the EPR effect (adapted from2). Tumour vessels
are structurally irregular and leaky compared to normal vessels. Endothelial
cells can’t form a normal monolayer, overlap and nanoparticles enter through
the gaps in the tumour vasculature.
It should be also noted that vessel permeability varies during tumour
progression (due to a high interstitial fluid pressure) which can decrease the
ability of particles to extravasate15.
The surface properties of the drug carrier are also crucial in determining
the biocompatibility, biodistribution and retention within the circulatory
system.
The modification of the nanoparticle surface with hydrophilic moieties,
like PEG, creates a hydrodynamic barrier that prevents recognition and
uptake by the RES, reducing the toxicity of the carrier and increasing its
circulation half-life16.
Cancer cells often display increased cell surface expression of proteins
that may be found at low levels on normal cells as well as proteins that are
found exclusively on cancer cell surfaces. In this sense, chemical attachment
of a cell-specific ligand to the surface of the carrier that strongly interacts
with antigens (or receptors) displayed on the target tissue, can introduce a
specific (active) targeting to the drug-encapsulating nanoparticle15.
The use of a targeting moiety decreases adverse side effects by allowing the
drug to be delivered to the specific site of action and facilitates cellular up-
take of the drug by receptor-mediated endocytosis. Folate, transferrin and
Luteinizing hormone-releasing hormone are examples of targeting ligands
reported in literature17.
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2.3 Dendritic polymers
2.3.1 Fundamentals
Dendritic polymers constitute a recent and attractive family of polymers
with unique structures and properties. Based on their branched controlled
structure, dendritic polymers can be classified into four main subgroups:
hyperbranched polymers, dendrigrafts, dendrons and dendrimers3. These
dendritic architectures are closely related to each others but reflect the level
of control over the branching units used to synthesize these assemblies.
Figure 2.3: Representation of dendritic architectures (adapted from3).
The first dendritic wedge was reported by Vo¨gtle et al.18, in 1978, de-
scribing the synthesis of ‘cascade molecules’. In 1985, Tomalia group pro-
posed the term ‘dendrimer’ to describe a unique core-shell macromolecular
architecture19. The term ‘dendrimer’, originates from the Greek, is a com-
bination of the words dendron = tree and meros = part, and it was chosen
due to its treelike structure that may be found in innumerable examples in
nature20.
Dendrimers (or arborols) are multivalent macromolecules characterized
by a regular, globular and highly branched structure. One of the most
attractive properties of this architecture is the large number of peripheral
groups that may be modified to afford polymers with tailored properties.
Their distinct topology offers unique properties when compared to tradi-
tional linear polymers. Generally, they are more soluble in common solvents
compared to analogous linear polymers (increased free volume and periph-
eral groups)21. Solubility characteristics of dendrimers depend mainly on
the nature of the peripheral groups. Dendrimers terminated in hydrophilic
groups are soluble in polar solvents, while dendrimers having hydrophobic
end groups are soluble in nonpolar solvents.
Physical properties like viscosity and thermal behaviour also differ signifi-
cantly. The viscosity in solution is significantly lower than linear analogues.
For instance, studies conducted show that intrinsic viscosity decreases with
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higher generation dendrimers22; this behaviour is assigned to the transition
from an extended structure to a compact globular shape. The increase in
the number of end-groups lowers the glass transition temperature (Tg), that
comes closer to a final value after higher generations. Hawker and Chu
demonstrated that thermal properties also strongly depend on the proper-
ties of the terminal groups23.
Dendrimers have a three-dimensional well defined multi-branched ar-
chitecture with low polydispersity index (PDI) due to the high degree of
control over the process of synthesis that provides monodisperse polymers
(dendigraft and hyperbranched polymers are less controlled)24. Due to their
globular shape and the presence of internal cavities, dendrimers offer the
possibility to encapsulate guest molecules in the macromolecule interior25.
Therefore, a tremendous progress in the chemistry of dendrimers has been
observed, shifting the interest to the potential applications of these poly-
meric materials: catalysis, sensors, micelles and encapsulation, contrast
agents, liquid crystalline materials, among others21.
The structural diversity in the repeat units is impressive and a wide variety
of architectures have been created, including poly(amidoamine) (PAMAM),
poly(propylene imine) (PPI), polyether and bis-MPA based dendrimers26.
Dendrimers structure consists of three basic architectural components:
the core, the interior and the end-groups (see Figure 2.4).
The core is positioned at the center and to it branched wedges are at-
tached. The number of branched points encountered upon moving outward
from the core to the periphery represents the generation number. Increasing
the number of generations, higher branching density and wider structures
will be created with amplification of the peripheral functionalities.
Figure 2.4: Schematic representation of a dendrimer.
Dendrimers can be tailored by the nature of the core, the type of building
blocks and the functional groups at the periphery. Physical and chemical
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properties as well as overall size, shape and flexibility are strongly influenced
by each one of this architectural component that exhibits a specific function
at the same time that defines unique properties for these nanostructures, as
they grow generation by generation24.
The surface groups with appropriate functionalization allow the mod-
ulation of interfacial properties and the interaction with the surrounding
environment, enhancing the biocompatibility and enabling the design of mul-
tifunctional dendrimers27. They may also act as reactive gates controlling
the releasing of guest molecules from the interior of the dendrimer.
The higher degree of control over the highly branched structure and
the ability to tailor dendrimers properties to therapeutic needs (reducing
experimental and therapeutic repeatability) make them ideal for targeted
drug-delivery, macromolecular carriers, surface engineering and biomimetic
applications28.
2.3.2 Synthesis methodologies
Dendrimers synthesis requires multi-step synthetic routes with laborious
and time consuming activation/protection steps, condensation reactions and
purifications processes to remove excess of reagents and byproducts, since is
the only way to achieve overall control over the final structure21.
For the synthesis of dendrons and dendrimers by step-by-step sequences,
two main strategies have emerged: the convergent and the divergent growth
approaches (see Figure 2.5). In both ways, dendrimers can be prepared with
high precision and controlled molecular weight4. Based on the characteris-
tics of the target molecule, the chemical steps during the synthesis and the
building blocks used in the design of the dendritic structure, the choice of a
synthetic route is done29.
Both methods require two steps for the growth of each generation: the
activation of the dendritic unit and the addition of new monomer.
In the divergent approach, pioneered by Newkome30 and Tomalia19 in
1985, the dendrimer grows radially outwards from a multifunctional core
site by repetitive cycles of addition of molecules, layer-by-layer.
The increase number of terminal groups of every layer aggravate the addi-
tion of new monomer at higher generations due to a sterically hindered sur-
face. Problems may occur from side reactions and incomplete reactions that
lead to structural defects, causing difficulties when purifying these materi-
als. Thus, excess of reagent and full substitution of the end-groups through
deprotection/activation reactions are needed to afford regular branching29.
The first PAMAM dendrimers were synthesized by this approach24.
In the convergent approach, developed by Hawker and Fre´chet31, den-
drimer is constructed stepwise, starting from the periphery inward to a focal
point. Dendrons are synthesized separately and in a final step coupled to a
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Figure 2.5: Schematic representation of convergent and divergent synthetic
routes.
multifunctional core molecule to afford the final dendrimer.
The advantages of this strategy are the precise control in each step of the
dendritic structure and the simpler purification procedures due to the differ-
ence in molecular weight and polarity between products and byproducts32.
However, this method is usually limited to dendrimers of lower generations
due to steric hindrance that potentially difficult the last coupling step in
large dendrons28.
Considering the large number of steps involved in the synthesis and pu-
rification of higher generation dendrimers as well as their time-consuming
synthesis, it is desirable to reduce the number of synthetic steps and to
improve the overall yield of the final dendrimer.
This could be achieved in a double-stage convergent growth approach,
where the monodendrons containing a single reactive group at the focal point
are coupled in a divergent manner to the periphery of a dendron prepared
by a convergent or divergent growth approach4 (see Figure 2.6).
This approach enhance the versatility of the synthesis, reduce the number
of growth steps and facilitate the purification of the final product.
2.3.3 Biocompatibility
A major concern when introducing a new class of nanoparticles for med-
ical applications is directed towards the biocompatibility of these particles.
In order to use them in drug delivery applications, dendrimers have to ful-
fill certain requirements: non-toxic, non-immunogenic and biodegradable.
12
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Figure 2.6: Schematic representation of a double-stage convergent growth
approach of a dendron (adapted from4).
Moreover, they should be able to circulate in the body for the time needed
to have a clinical effect and display an inherent body distribution that will
allow appropriate tissue targeting33.
The nature of the dendrimers end-groups dictate whether or not it dis-
plays a significant toxicity. A difference was observed between the toxicity
of cationic dendrimers and neutral or anionic dendrimers. Studies shown
that PAMAM and PPI dendrimers with terminal primary amines gener-
ally display concentration-dependent toxicity and haemolysis whereas den-
drimers containing neutral or anionic groups had shown to be less toxic and
haemolytic; lower-generation PAMAM dendrimers with carboxylate end-
groups show neither haematotoxicity nor cytotoxicity at concentrations up
to 2 mg/ml34. It was also clarified that biocompatibility of dendrimers is not
only determined by the surface groups: dendrimers containing an aromatic
core may cause haemolysis through hydrophobic membrane contact.
In this sense, it is of interest to develop and assess novel water-soluble and
biocompatible dendritic structures. Studies of polyester-based dendrimers
based on bis-MPA were carried out and showed a low toxicity profile both
in vitro and in vivo. Since the dendrimer may be degraded by hydrolytic
enzymes after the release of the drug, this system is a promising polymeric
backbone in the development of well-defined drug carriers35.
2.4 Stimuli-responsive polymers
Stimuli-responsive polymers (or smart polymers) are materials that re-
versibly change their physicochemical characteristics in response to a narrow
variation in surrounding environmental conditions. Stimuli, such as pH,
temperature, ionic strength, electromagnetic radiation, mechanical forces,
13
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magnetic and electric fields can lead to different type of responses: degrada-
tion, swelling/collapsing, conformational change, drug release, among oth-
ers36.
Progressive developments in polymerization techniques allow the design
of smart polymers with controlled molecular weight, architecture and prop-
erties that define the polymer response1.
Nanocarriers systems with triggering mechanisms offer great advantages
in drug delivery for biomedical applications. While traditional systems act
exclusively as passive drug carriers, these systems undergo changes in their
nature in response to pathological triggers that stimuli the drug release.
This feature lead to a maximal therapeutic efficacy at the disease site while
reduce undesired side effects5.
Although several smart polymers have been exploited, most of the work
reported is related to pH- and temperature-responsive polymers, mainly, be-
cause these properties are important physiological indicators and are easily
controlled.
This strategy allow us to aim further for tailor-made DDS with superior
pharmacokinetics while having all safety questions addressed (e.g., problems
associated with traditional chemotherapy).
2.4.1 Temperature-responsive polymers
Since temperature is one of the most important physiological indica-
tors, any deviation from normal values can act as a trigger for temperature-
responsive polymers.
These polymers exhibit a volume phase transition at a critical solution
temperature which causes a change in the solvation state (leading to the
formation of hydrophobic domains)36. The polymer chain collapse or ex-
tend, responding to hydrophobic and hydrophilic interactions between the
polymer and the aqueous medium1.
Typically, thermo-responsive polymers are soluble, in aqueous solution,
below their lower-critical solution temperature (LCST) due to the hydro-
gen bounding with water molecules (expanded state). Upon heating, they
become insoluble and dehydrated (compact globule)37. Above the LCST,
intra- and intermolecular interactions between the hydrophobic molecules
are favored compared to a solubilisation by water molecules and the polymer
undergoes an abrupt change in the specific volume38 (see Figure 2.7). The
balance between the hydrophilic and hydrophobic groups along the polymer
chain determines the LCST.
Thermal responsive character of these polymers broadens the possibili-
ties of DDS applications. For example, body-site temperature can change
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upon local infection and therapeutic agents may be release as result of a
trigger if the LCST of the material is close to body temperature.
Mild clinical hyperthermia (42 ◦C) damage cancer cells or make them
more sensitive to the effects of radiation and anticancer drugs. It also af-
fects the biological functions of cancer cells (e.g., decreased DNA synthesis,
disrupted microtubules, altered receptor expression) without biological dam-
age to normal cells39.
So, the combination of thermo-responsive polymers with local hyperthermia
condition at the solid tumour could provide more effective treatment.
Figure 2.7: Polymer response to temperature (adapted from5).
Poly(N-vinyl caprolactam) (PVCa) and poly(N-isopropylacrylamide) (PNI-
PAAm) are examples of temperature sensitive polymers reported.
PVCa possess very interesting properties for biomedical applications:
biocompatibility, low toxicity, high absorption ability, solubility in water and
organic solvents (due to the presence of hydrophilic and hydrophobic groups
in its structure) and LCST close to the body temperature (32 ◦C)40;41.
PNIPAAm has been used, for example, in drug targeting, thermo-sensitive
coatings or micelles for controlled release of drugs42. It exhibits a LCST
around 32 ◦C (pH ∼ 7) and it is, probably, the most used macromolecule
in temperature-responsive hydrogels. Above this temperature, a reversible
conformational transition occurs from expanded coil (soluble) to compact
globule (insoluble). Its distinctive behaviour is attributed to the rapid alter-
ation of hydrophilicity. The amphiphilic chains hide the hydrophilic amide
groups and expose the hydrophobic isopropyl groups in the compact globule
conformation43.
Despite promising studies, PNIPAAm is not the ideal candidate for
biomedical applications due to its non-degradable, insoluble nature and un-
clear effect in the body44.
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2.4.2 pH-responsive polymers
pH variations within the body can be also used as a tool for drug carriers
systems. pH-responsive polymers have been proposed for different biomed-
ical applications, especially for entrapment and delivery of bioactive agents
(since different organs or tissues have specific pH)43.
These polymers have weak acid or basic functional groups (e.g., car-
boxylic acids, amines, etc.) attached to the backbone. The ionization state
of the pendant group changes upon variation of the pH causing a modifica-
tion of the water solubility of the chains1.
The aqueous solubility of a pH-responsive polymer depends on the pH
of the solution because variation around the pKa value causes protonation
or deprotonation of the polymer chains45.
For example, carboxylic pendant groups of poly(acrylic acid) at low pH
accept protons, while release them above its pKa (4.28). Therefore, the
polymer exhibits a collapsed conformation at low pH and an expanded state
at high pH. The opposite effect is observed for polybases43.
To attain pH sensitive polymers, the most explored monomers are acrylic
acid (AA) and methacrylic acid (MAA). Poly(ethylene imine) (PEI) and
poly(2-(diisopropylamino)ethyl methacrylate) (PDIPAEMA) are also exam-
ples reported in literature36.
Poly(2-(dimethylamino)ethyl methacrylate) (PDMAEMA) is an exam-
ple of a dual temperature/pH-responsive polybase (respond independently
and simultaneously to temperature, 38− 40 ◦C, and pH, pKa ∼ 2.5).
Tumour tissue (as well as inflamed or wound tissue) exhibits a extracellu-
lar pH more acidic (∼ 6.5−7.2) when compared to the normal physiological
extracellular pH (∼ 7.35 − 7.45)36. In this sense, responsive systems can
be useful to release bioactive agents by pH-triggering at the physiological
environment.
For instance, in non-viral gene therapy, the intracellular delivery of nu-
cleic acids usually uses cationic polymers which complex the negatively
charged molecules. Once the target tissue is reached, cellular uptake of
the complex take place through pinocytosis or receptor-mediated endocyto-
sis. In response to the acidification of the medium, the polycations trigger
endossome membrane disruption and release its content into the cytosol due
to the proton-sponge effect (see Figure ??)36.
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2.5 Linear-dendritic block copolymers
2.5.1 Structural characteristics
Bioinspired smart block copolymers represent a new class of functional
materials with tremendous applications in drug delivery.
Amphiphilic block copolymers consist of at least of an hydrophobic seg-
ment attached to an hydrophilic segment. In solution, the amphiphilic block
copolymer chains tend to organize themselves into various ordered structures
when the critical micelle concentration (CMC) and/or the critical micelle
temperature (CMT) are achieved. Spherical micelles are the most common
self-assemble structures, among the many supramolecular structures possi-
ble, and are promising drug delivery carriers for hydrophobic therapeutic
agents.
From the combination of dendritic structures with linear segments, it
is possible to design unique biomimetic hybrids with novel macromolecular
architectures such as linear-dendritic block copolymers (LDBC), rod coils
or multi-arm star polymers46–48.
This hybrid system combines the advantages of regular spherical dendrimers
with the phase segregation behaviour of traditional linear block copolymers.
The macromolecular system is biocompatible and biodegradable, provides a
high density functional surface that can be used to cluster ligands for efficient
targeting and sensing capabilities and forms extremely stable micelles with
an unusual low CMC due to the semirigid rod nature of the comb block that
takes a unique cone shape, yielding self-assembly behaviour6.
By tuning the chemical nature, size and length of the blocks, a broader
extent of controlled properties can be obtained.
Figure 2.8: Formation of micelles from a amphiphilic linear-dendritic diblock
copolymer (adapted from6).
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2.5.2 Synthesis methodologies
Living radical polymerization
Living radical polymerization (LRP) emerged to overcome the limita-
tions of the conventional free radical polymerization (FRP). This method
combines the advantages of the FRP, such as easy procedure, water-friendly
and compatibility with several functional monomers with the ability of the
synthesis of well-defined polymers, due to a strict control over the macro-
molecular properties - molecular weight distribution, chain length, topology,
composition, functionality and architecture49;50.
Controlled LRP strategies rely on the dynamic equilibrium between
growing radicals and dormant species, based on a fast activation/deactivation
process. This mechanism decreases the number of growing radicals com-
pared to the traditional FRP51. Therefore, the living character of the poly-
mer chains allows further reinitiating by adding new monomers, which leads
to the easy preparation of controlled block copolymers.
‘Click’ chemistry
This concept was first introduced by Sharpless in 2001 with the aim of
binding two molecular blocks together in an easy, selective and high-yield
reaction, under mild conditions with no byproducts52. Among the several
‘click’ reactions reported, the most used that can fulfill these conditions is
the copper-catalyzed azide/alkyne cycloaddition (CuAAC)53.
One specific cycloaddition reaction is the 1,3-dipolar cycloaddition be-
tween azido and alkynyl groups in the presence of copper (I) salts yielding
1,4-disubstituted 1,2,3-triazoles (see Figure 3.3). This ‘click’ chemistry re-
action has recently proved to be a very powerful synthetic tool due to its
easy procedure, high selectivity and conversion (obtained under mild reac-
tion conditions)54. However, the copper component may be a problem if
traces remain under physiological conditions.
Figure 2.9: 1,3-dipolar cycloaddition between azido and alkynyl groups cat-
alyzed by copper salts.
18
2.5 Linear-dendritic block copolymers Theoretical Background
‘Click’ reactions are a useful tool not only for LDBC synthesis but also
in functionalization strategies55. Applications are largely expanding in the
fields of organic synthesis, dendritic polymers (e.g., surface functionaliza-
tion of dendrimers, molecular recognition and nanoparticle catalysis) and
biomacromolecules56.
Indeed, the CuAAC reaction is a suitable solution to several problems in
polymer science: reaction conditions are more attractive than conventional,
purification is easier and the triazole ‘bridge’ is considered to be biologically
stable.
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3.1 Characterization techniques
3.1.1 Nuclear magnetic resonance
Nuclear magnetic resonance (NMR) spectroscopy exploits the magnetic
properties of certain atoms, studying the transitions between different quan-
tized energy levels when an external magnetic field is applied. This technique
allows qualitative and quantitative analyses of compounds mixtures and de-
termination of molecular structures, due to the dependence of frequency and
intensity of signals with the molecular architecture of the sample.
Hydrogen (1H), carbon (13C) and fluorine (19F) nuclei are frequently
used in NMR spectroscopy analysis. For instance, 1H nucleus has a high
relative abundance and it is very sensitive to the presence of external mag-
netic fields. To perform this analysis, deuterated solvents are frequently
used such as chloroform-d (CDCl3) or water-d2 (D2O)
57.
The resulting NMR spectrum present several absorption peaks, providing
helpful information (number, position and intensity of signals) about the
molecular structure of the compounds, that will be discussed below.
Protons with different environments absorb to different magnetic induc-
tions. Thus, the number of signals in the spectrum translates the number
of protons chemically equivalent that exist in the molecule.
The position of the signals in the NMR spectrum is a source of information
about the electronic environment of each specie of protons. The reference
point is generally the signal of tetramethyilsilane (TMS), whose protons are
chemically equivalent causing a narrow single signal at position 0.0. The
chemical shift (δ), or offset, characterizes a proton in its environment and
corresponds to the position of an absorption peak in relation to the refer-
ence. So, chemically equivalent protons have the same chemical shift and
the more protected are the nuclei, the smaller the chemical shift is (and vice
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versa).
The signal intensity depicts how many protons of each specie exist in the
molecule. The area below each peak (integration) is proportional to the
number of protons that triggered the signal58.
3.1.2 Fourier transform - infrared spectroscopy
Infrared spectroscopy is a characterization technique widely used to as-
sess the light absorbed by a sample at each wavelength of the infrared spec-
trum, allowing the characterization of chemical processes (e.g., vibration
of interatomic bonds) and molecular structure. When a sample is exposed
to infrared light, it absorbs radiation at certain frequencies that are char-
acteristic of the chemical bonds present in the molecule. Thus, an infrared
spectrum represents the fingerprint of a sample with absorption peaks which
correspond to the frequencies of vibrations between the bonds of the atoms
that makeup the compound, leading to a qualitative analysis.
Fourier transform - infrared spectroscopy (FT-IR) has a high sensitiv-
ity, resolution and short scan time. Generally, sample analysis is performed
in reflectance or transmission modes. In the second case, matrix isolation
techniques (e.g., KBr or CsI) are needed to prepare the sample. In the first
one, samples can be examined directly in the solid or liquid state without
further preparation.
Attenuated total reflectance (ATR) operates by measuring the changes that
occur in a totally internally reflected beam when it comes into contact with
the sample. An infrared beam is directed onto a crystal (with a high refrac-
tive index) in such a way that it reflects off the internal surface in contact
with the sample. This internal reflectance creates an evanescent wave that
extends beyond the surface of the crystal into the sample57.
3.1.3 Matrix-assisted laser desorption ionization
Matrix-assisted laser desorption ionization is an analytical mass spec-
trometry technique that measures the mass-to-charge ratio (m/z) of ions,
allowing the analysis of biomolecules and organic macromolecules (e.g., den-
drimers, hyperbranched polymers, etc.). In time-of-flight method, ions are
bombed by a high-energy electron beam, ionize and cleave. The time it
takes for the ions to travel from the analyzer to the detector is measured
and is proportional to their m/z (linear mode). Each set of ions formed has
a certain value of m/z and the intensity of each signal reflects the relative
abundance of the ion that produces it.
In this sense, MALDI-TOF-MS allow the determination of the molecular
weight, formula, and can assess the presence of structural units whithin the
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molecule58.
3.2 Materials
bis-MPA (98%, Aldrich), 2,2-dimethoxypropane (98%, Sigma-Aldrich),
sodium sulfate (Na2SO4) anhydrous (JMGS, Lda), Dowex 50WX2-200 H
+-
exchange resin (Sigma-Aldrich), N,N’ -Dicyclohexylcarbodiimide (DCC) (99%,
Aldrich), benzyl bromide (98%, Aldrich), pyridine (≥ 99%, Sigma-Aldrich),
silica 60A 60µm-200µm chromatography (Fisher Scientific), TLC silica gel
60 F254 (Merck Chemicals), deuterated chloroform (CDCl3) (99.96%, Aldrich),
palladium on carbon (Pd/C) 10 wt.% (Aldrich), propargyl bromide solution
(80 wt.% in toluene, Aldrich), potassium hydroxide (KOH) (≥ 85%, Sigma-
Aldrich), N,N’ -Diisopropylcarbodiimide (DIC) (99%, Aldrich), propargy-
lamine (98%, Aldrich), propiolic acid (95%, Aldrich), N -(3-Dimethylamino-
propyl)-N’ -ethylcarbodiimide hydrochloride (EDC) (≥ 98%, Fluka), 1,1’-
carbonyldiimidazole (CDI) (≥ 97%, Aldrich), 4-pentynoic acid (98%, Acros
Organics), 3-butyn-1-ol (98%, GFS Chemicals), 4-pentyn-1-ol (95%, Acros
Organics), sodium hydroxide (NaOH) (Merck Chemicals), sodium chloride
PA (Panreac), celite hyflo super cel (Panreac), sodium hydride (60%) (NaH),
2-(4-hydroxyphenylazo)benzoic acid (HABA) (99.5%, Sigma-Aldrich), α-
cyano-4-hydroxycinnamic acid (HCCA) (99.5%, Sigma-Aldrich), N,N -Di-
methylformamide (DMF) (99%, Fisher Scientific), hexane (JMGS, Lda),
ethyl acetate (EtOAc) (≥ 99.97%, Fisher Scientific), 1,2-dichloroethane
(Fluka), toluene (99.9%, Fisher Scientific), diethyl ether (Panreac) and metha-
nol (JMGS, Lda) were used as received (without further purification).
Triethylamine (≥ 99.0%, Sigma-Aldrich), dichloromethane (CH2Cl2)
(≥ 99.99%, Fisher Scientific), tetrahydrofuran (THF) (≥ 99.97%, Fisher Sci-
entific) and acetone (JMGS, Lda) were distilled before used. p-toluenesulfonic
acid monohydrate (TsOH) (≥ 98.5%, Sigma-Aldrich) and poly(ethylene gly-
col) methyl ether Mn ∼ 2000 (Aldrich) were dried by azeotropic distillation
in toluene. 4-(Dimethylamino)pyridine (DMAP) (99%, Aldrich) was puri-
fied by recrystallization.
4-(Dimethylamino)pyridinium p-toluenesulfonate (DPTS) was synthe-
sized according to the general procedure developed by Moore59. TsOH
monohydrate was dried by azeotropic distillation of a toluene solution. An
equimolar solution of DMAP in warm toluene was then added to the flask
and the two solutions were mixed thoroughly. The resulting suspension was
cooled to room temperature (RT) and the solid collected by filtration. The
crude product was purified by recrystallization from dry dichloroethane,
yielding white crystals.
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3.2.1 Techniques
1H NMR analyses were performed on a Bruker Avance III 400 MHz
spectrometer with a warm 5 mm TXI triple resonance detection probe in
CDCl3 with TMS as an internal standard, in Nuclear Magnetic Resonance
Laboratory of Coimbra Chemistry Centre.
For MALDI-TOF-MS analysis, the sample was dissolved in THF at a
concentration of 10 mg/mL. HABA and HCCA (0.05 M in THF) were used
as matrix. The dried-droplet sample preparation technique was used to
obtain 1/1 ratio (sample/matrix); an aliquot of 1 µL of each sample was
directly spotted on the MTP AnchorChip TM 600/384 TF MALDI tar-
get, Bruker Daltonik (Bremen, Germany), and before the sample dry, 1 µL
of matrix solution in THF was added and allowed to dry at RT, to permit
matrix crystallization. External mass calibration was performed with a pep-
tide calibration standard (PSCII) for the range 700-3000 (9 mass calibration
points); 0.5 µL of the calibration solution and matrix previously mixed in an
eppendorf tube (1/2, v/v) were applied directly on the target and allowed to
dry at RT. Mass spectrum was recorded using an Autoflex III smartbeam1
MALDI-TOF mass spectrometer Bruker Daltonik operating in the linear
mode. Ions were formed upon irradiation by a smartbeam1 laser using a
frequency of 200 Hz. The mass spectrum was produced by averaging 2500
laser shots collected across the whole sample spot surface by screening in the
range m/z 750-3000. The laser irradiance was set to 35-40% (relative scale
0-100) arbitrary units according to the corresponding threshold required
for the applied matrix systems. The MALDI-TOF-MS data was obtained
by Dra. Paula A´lvarez Chaver at Unidad de Espectrometria de Masas do
Servizo de Determinacio´n Estructural, Proteo´mica e Xeno´mica, Centro de
Apoio Cient´ıfico e Tecnolo´xico a´ Investigacio´n (CACTI), Universidade de
Vigo (Spain).
ATR-FTIR analyses were carried out on a JASCO FT/IR - 4200 spec-
trometer at RT for the range 4000-500 cm−1, using 64 scans and a 4 cm−1
spacial resolution.
3.2.2 Computational procedures
NMR spectra processing and analysis were carried out using MestReNova
software. CS ChemDraw was utilized as drawing tool for chemical structures
and GraphPad Prism was employed in analysis and graph of ATR-FTIR and
MALDI-TOF-MS data.
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3.3 Synthesis strategies
3.3.1 Double-stage convergent growth approach
The general procedures, chemical shifts (in ppm) and synthetic reactions
schemes are presented below.
Synthesis of isopropylidene-2,2-bis(methoxy)propionic acid [1]
Figure 3.1: Isopropylidene-2,2-bis(methoxy)propionic acid synthesis reac-
tion.
bis-MPA hydroxyl groups were protected to afford acetonide group by re-
acting bis-MPA (10.03 g, 74.77 mmol) with 2,2-dimethoxypropane (13.8 mL,
111.83 mmol) in distilled acetone (50 mL), catalyzed by TsOH anhydrous
(0.71 g, 4.12 mmol). The reaction was stirred for 3 h at RT under N2 atmo-
sphere and the catalyst was neutralized by adding an equimolar solution of
distilled triethylamine (0.41 g, 4.12 mmol). The solvent was evaporated, the
residue was dissolved in CH2Cl2 and extracted with two portions of distilled
water. The organic phase was dried with Na2SO4 anhydrous, filtered and
the solvent evaporated to afford [1] as a white powder (6.77 g, 60%). 1H
NMR (CDCl3): δ 1.20 (s, 3H, −CH3), 1.43 (s, 3H, −CH3), 1.46 (s, 3H,
−CH3), 3.68 (d, 2H, −CH2O), 4.16 (d, 2H, −CH2O).
Synthesis of benzyl-2,2-bis(methylol)propionate [2]
Figure 3.2: Benzyl-2,2-bis(methylol)propionate synthesis reaction.
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bis-MPA (9.01 g, 67.71 mmol) and KOH (4.34 g, 77.35 mmol) were dis-
solved in 50 mL of DMF and the potassium salt was allowed to form at 100 ◦C
for 1 h. Benzyl bromide (13.81 g, 80.74 mmol) was then added to the mix-
ture. The reaction was stirred (800 rpm) for 15 h and then the solvent was
evaporated off. The residue was dissolved in CH2Cl2 (∼ 200 mL), extracted
with three portions of distilled water, dried and the solvent was evaporated.
The viscous oil obtained was recrystallized from CH2Cl2/hexane to give [2]
as white crystals (9.31 g, 61%). 1H NMR (CDCl3): δ 1.08 (s, 3H, −CH3),
3.75 (d, 2H, −CH2OH), 3.94 (d, 2H, −CH2OH), 5.21 (s, 2H, −CH2Ar),
7.36 (m, 5H, ArH).
Synthesis of [G-2] dendron [3] and general esterification procedure
All esterification reactions were performed in distilled CH2Cl2 under Ar
atmosphere at RT by DCC coupling, using DPTS as catalyst.
Figure 3.3: [G-2] dendron synthesis reaction.
[1] (3.26 g, 18.70 mmol), [2] (2.01 g, 8.96 mmol) and DPTS (1.05 g,
3.57 mmol) were dissolved in 30 mL of distilled CH2Cl2 and the reaction
flask was flushed with Ar. DCC (4.61 g, 22.34 mmol) (in CH2Cl2) was then
added and the reaction mixture was stirred overnight at RT under Ar at-
mosphere. After reaction completion, the DCC-urea byproduct was filtered
off in a glass filter (with celite) and the residue was extracted with three
portions of distilled water, dried and concentrated. The crude product was
purified by liquid column chromatography on silica gel, eluting with hexane
and gradually increasing to 50:50 EtOAc:hexane, to give [3] as a colorless
viscous oil (2.99 g, 79%). 1H NMR (CDCl3): δ 1.10 (s, 6H, −CH3), 1.30 (s,
3H, −CH3), 1.34 (s, 6H, −CH3), 1.41 (s, 6H, −CH3), 3.56 (d, 4H, −CH2O),
4.09 (d, 4H, −CH2O), 4.34 (s, 4H, −CH2C), 5.16 (s, 2H, −CH2Ar), 7.34
(m, 5H, ArH).
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General procedure for removal of benzyl ester group [4]
Figure 3.4: [G-2] dendron deprotection reaction of benzyl ester group.
The benzyl ester group was selectivity removed by catalytic hydrogenol-
ysis performed at atmospheric pressure using Pd/C as catalyst. [3] (3.00 g,
5.59 mmol) was dissolved in EtOAc (25 mL) and 0.30 g of Pd/C (10%) was
added to the solution. The flask was evacuated from air and filled with H2
and the reaction was stirred for 24 h at RT. The catalyst was filtered off
(with celite) and the solvent was evaporated to give [4] as a colorless viscous
oil (2.29 g, 92%). 1H NMR (CDCl3): δ 1.16 (s, 6H, −CH3), 1.32 (s, 3H,
−CH3), 1.36 (s, 6H, −CH3), 1.42 (s, 6H, −CH3), 3.62 (d, 4H, −CH2O),
4.15 (d, 4H, −CH2O), 4.35 (s, 4H, −CH2C).
General procedure for removal of acetonide protective groups [5]
Figure 3.5: [G-2] dendron deprotection reaction of acetonide groups.
[3] (4.00 g, 7.45 mmol) was dissolved in 50 mL of methanol and approx-
imately one teaspoon of Dowex H+ resin was added to the solution. The
reaction was stirred for 12 h under mild conditions and monitored by thin-
layer chromatography (TLC). After reaction completion, the acidic Dowex
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resin was filtered off in a glass filter (with celite) and the methanol was evap-
orated. To effectively isolated it, the crude product was then dissolved in
EtOAc and washed with two portions of brine. The organic phase was dried
with Na2SO4 anhydrous and concentrated to afford [5] as a powder (1,87
g, 55%). 1H NMR (CDCl3): δ 0.98 (s, 6H, −CH3), 1.32 (s, 3H, −CH3),
3.64-3.81 (m, 8H, −CH2OH), 4.29 (d, 2H, −CH2C), 4.44 (d, 2H, −CH2C),
5.18 (s, 2H, −CH2Ar), 7.35 (m, 5H, ArH).
Synthesis of [G-4] dendron [6]
Figure 3.6: [G-4] dendron synthesis reaction.
The fourth generation dendron was attained by a coupling reaction ac-
cording to the esterification general procedure. [4] (1.18 g, 2.64 mmol), [5]
(207 mg, 0.45 mmol) and DPTS (515 mg, 1.75 mmol) were dissolved in 15
mL of distilled CH2Cl2 and flushed with Ar. DCC (589 mg, 2.85 mmol) was
then added and the reaction mixture was stirred for 48 h at RT under Ar
atmosphere. After reaction completion, the DCC-urea byproduct was fil-
tered off in a glass filter and the residue was extracted with two portions of
water; it was dried (with Na2SO4 anhydrous) and concentrated. The crude
product was purified by liquid column chromatography on silica gel, eluting
with hexane and gradually increasing to 80:20 EtOAc:hexane, to give [6] as
a colorless viscous oil (891 mg, 91%). 1H NMR (CDCl3): δ 1.14 (s, 24H,
−CH3), 1.16 (s, 6H, −CH3), 1.26 (s, 12H, −CH3), 1.29 (s, 3H, −CH3),
1.35 (s, 24H, −CH3), 1.41 (s, 24H, −CH3), 3.60 (d, 16H, −CH2O), 4.13 (d,
16H, −CH2O), 4.20-4.33 (m, 28H, −CH2C), 5.16 (s, 2H, −CH2Ar), 7.35
(m, 5H, ArH).
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Removal of the benzyl ester group of [G-4] dendron [7]
Figure 3.7: [G-4] dendron deprotection reaction of benzyl ester group.
The benzyl ester group was selectivity removed by catalytic hydrogenoly-
sis according to the general procedure. [6] (3.09 g, 1.42 mmol) was dissolved
in EtOAc (50 mL) and 0.31 g of Pd/C (10%) was added to the solution.
The reaction mixture was stirred for 24 h at 30 ◦C at 10 atm. The catalyst
was filtered off (with celite) and the solvent was evaporated to give [7] as a
colorless viscous oil (2.1 g, 71%). 1H NMR (CDCl3): δ 1.14 (s, 24H, −CH3),
1.26 (s, 18H, −CH3), 1.28 (s, 3H, −CH3), 1.35 (s, 24H, −CH3), 1.42 (s,
24H, −CH3), 3.61 (d, 16H, −CH2O), 4.14 (d, 16H, −CH2O), 4.20-4.33 (m,
28H, −CH2C).
Alkyne functionalization of [G-4] dendron
An overview of the reactions carried out to accomplish the alkyne func-
tionalization of the core of the dendrons is shown in Table 3.1.
General procedure: [7] and 3-butyn-1-ol were dissolved in distilled CH2Cl2
and the flask was flushed with N2. The reaction mixture was cooled in an
ice bath and a solution of DCC (in CH2Cl2) was added while stirring. A so-
lution of DMAP was added dropwise under N2 atmosphere and the mixture
was stirred in the cooling bath for 1 h and then for 24 h at RT. The solution
was filtered off with a glass filter, quenched with water and washed with a
NaOH (5%) solution. The organic phase was dried with Na2SO4 anhydrous
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and the solvent was evaporated. The crude product was purified by liquid
column chromatography (on silica gel and eluting with 20:80 EtOAc:hexane)
to afford a viscous oil.
3.3.2 Dendron growth via anhydride chemistry
Synthesis of isopropylidene-2,2-bis(methoxy)propionic acid anhy-
dride [A1]
Figure 3.8: Isopropylidene-2,2-bis(methoxy)propionic acid anhydride syn-
thesis reaction.
[1] (4.80 g, 27.6 mmol) was dissolved in 50 mL of distilled CH2Cl2 and
flushed with N2. DCC (2.85 g, 13.8 mmol) was added to the mixture and the
reaction was continued for 15 h at RT under N2 atmosphere. After reaction
completion, DCC-urea byproduct was filtered off in a glass filter (2x) and
the solvent was evaporated. The residue was dried under vacuum to obtain
[A1] as a viscous oil (4.56 g, 95%). 1H NMR (CDCl3): δ 1.24 (s, 6H, −CH3),
1.40 (s, 6H, −CH3), 1.44 (s, 6H, −CH3), 3.67 (d, 4H, −CH2O), 4.20 (d,
4H, −CH2O).
General procedure for the anhydride coupling reaction (synthesis
of [A2])
Figure 3.9: Anhydride coupling synthetic reaction.
Propargyl alcohol (261 mg, 4.66 mmol), DMAP (85 mg, 0.70 mmol) and
pyridine (1.11 g, 14.01 mmol) were dissolved in 20 mL of distilled CH2Cl2
and flushed with N2. [A1] (2.00 g, 6.05 mmol) was then added dropwise.
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The mixture was stirred for 48 h at RT under N2 atmosphere and moni-
tored by TLC. The reaction was quenched with water (to remove excess of
anhydride), washed with brine (2x) and the organic phase was dried with
Na2SO4 anhydrous and concentrated. If necessary, the crude product was
purified by liquid column chromatography on silica gel, eluting with hexane
and gradually increasing to 80:20 EtOAc:hexane, to give [A2] as a colorless
viscous oil (0.82 g, 64%). 1H NMR (CDCl3): δ 1.22 (s, 3H, −CH3), 1.39
(s, 3H, −CH3), 1.43 (s, 3H, −CH3), 2.47 (t, 1H, −C ≡ CH), 3.65 (d, 2H,
−CH2O), 4.20 (d, 2H, −CH2O), 4.74 (d, 2H, −CH2C ≡ CH).
Removal of acetonide protective groups [A3]
Figure 3.10: Deprotection reaction of acetonide groups of [A2].
[A2] was deprotected according to the general procedure for the removal
of acetonide protective groups (71%). 1H NMR (CDCl3): δ 1.10 (s, 3H,
−CH3), 2.50 (t, 1H, −C ≡ CH), 3.73 (d, 2H, −CH2O), 3.93 (d, 2H,
−CH2O), 4.77 (d, 2H, −CH2C ≡ CH).
Synthesis of [G-2] dendron [A4]
Figure 3.11: [G-2] dendron synthesis reaction.
General procedure for dendritic generation growth through anhydride
coupling reaction: [A3] (580 mg, 3.36 mmol), DMAP (230 mg, 1.88 mmol)
and pyridine (3.30 g, 41.77 mmol) were dissolved in 30 mL of distilled
CH2Cl2 and flushed with N2. [A1] (3.07 g, 9.28 mmol) was then added
and the solution was stirred for 24 h at RT under N2 atmosphere. The re-
action was monitored by TLC until total completion. It was washed with a
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solution of NaOH (10%) and the organic phase was dried, filtered, concen-
trated and purified by liquid column chromatography on silica gel, eluting
with hexane and gradually increasing to 80:20 EtOAc:hexane, to give [A4]
as a viscous oil (960 mg, 59%). 1H NMR (CDCl3): δ 1.16 (s, 6H, −CH3),
1.32 (s, 3H, −CH3), 1.36 (s, 6H, −CH3), 1.42 (s, 6H, −CH3), 2.48 (t, 1H,
−C ≡ CH), 3.61 (d, 4H, −CH2O), 4.14 (d, 4H, −CH2O), 4.34 (s, 4H,
−CH2C), 4.72 (d, 2H, −CH2C ≡ CH).
Removal of acetonide protective groups [A5]
Figure 3.12: [G-2] dendron deprotection reaction of acetonide groups.
[A5] was obtained according to the general deprotection procedure of
acetonide groups (previously reported) (56%). 1H NMR (CDCl3): δ 1.06
(s, 6H, −CH3), 1.25 (s, 3H, −CH3), 2.49 (t, 1H, −C ≡ CH), 3.70-3.88 (m,
8H, −CH2OH), 4.32 (d, 2H, −CH2C), 4.46 (d, 2H, −CH2C), 4.75 (d, 2H,
−CH2C ≡ CH).
Synthesis of [G-4] dendron [A6]
[A5] (37.7 mg, 0.093 mmol), [4] (250 mg, 0.56 mmol) and DPTS (110
mg, 0.37 mmol) were dissolved in 20 mL of distilled CH2Cl2 and the flask
was flushed with Ar. DCC (125 mg, 0.60 mmol) was added and the reaction
mixture was stirred for 48 h at RT under Ar atmosphere. Reaction byprod-
ucts were filtered off and the organic phase was extracted with three portions
of water, dried (with Na2SO4 anhydrous) and the solvent was evaporated.
The crude product was then purified by liquid column chromatography on
silica gel, eluting with hexane and gradually increasing the polarity to 80:20
EtOAc:hexane (148 mg, 75%). 1H NMR (CDCl3): δ 1.17 (s, 24H, −CH3),
1.31 (s, 18H, −CH3), 1.37 (s, 24H, −CH3), 1.42 (s, 24H, −CH3), 3.62 (d,
16H, −CH2O), 4.16 (d, 16H, −CH2O), 4.25-4.41 (m, 28H, −CH2C), 4.74
(−CH2C ≡ CH).
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Figure 3.13: Esterification reaction scheme.
Synthesis of ‘2nd generation’ anhydride [D1]
Figure 3.14: Anhydride synthesis reaction scheme.
[4] (2.10 g, 4.70 mmol) was dissolved in 20 mL of distilled CH2Cl2 and
bubbled with N2. DCC (0.49 g, 2.35 mmol) was then added to the mixture
and the reaction was continued for 24 h at RT under N2 atmosphere. After
reaction completion, DCC-urea byproduct was filtered off and the solvent
was evaporated (1.15 g, 55%). 1H NMR (CDCl3): δ 1.16 (s, 12H, −CH3),
1.32 (s, 6H, −CH3), 1.36 (s, 12H, −CH3), 1.42 (s, 12H, −CH3), 3.62 (d,
8H, −CH2O), 4.16 (d, 8H, −CH2O), 4.34 (m, 8H, −CH2C).
Synthesis of [G-3] dendron through anhydride coupling reaction
[D2]
[A3] (82.8 mg, 0.48 mmol), DMAP (15.3 mg, 0.12 mmol) and pyri-
dine (322.7 mg, 4.08 mmol) were dissolved in distilled CH2Cl2 (20 mL)
and flushed with N2. [D1] (0.91 mg, 5.29 mmol) was then added and the
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Figure 3.15: [G-3] dendron synthesis reaction.
solution was stirred for 24 h at RT under N2 atmosphere. The reaction
was monitored by TLC and then it was washed with distilled water (3x),
dried and concentrated. The product was purified by liquid column chro-
matography on silica gel, eluting with 20:80 EtOAc:hexane and gradually
increasing the polarity to 100% EtOAc (386 mg, 78%). 1H NMR (CDCl3):
δ 1.08-1.16 (m, 12H, −CH3), 1.28 (s, 6H, −CH3), 1.31 (s, 3H, −CH3), 1.36
(s, 12H, −CH3), 1.43 (s, 12H, −CH3), 2.45 (t, 1H, −C ≡ CH), 3.61 (d,
8H, −CH2O), 4.16 (d, 8H, −CH2O), 4.26-4.47 (m, 12H, −CH2C), 4.74
(−CH2C ≡ CH).
3.3.3 Alkyne functionalization of [1]
Figure 3.16: Synthesis reaction scheme.
[1] (1.74 g, 10.0 mmol) was dissolved in distilled THF (50 mL) and the
flask was flushed with N2. A solution of CDI (3.24 g, 20.0 mmol) was then
added and the reaction was stirred for 4 h at 25 ◦C (in a water bath) under Ar
atmosphere. Propargylamine (826 mg, 15.02 mmol) was then added and the
resulting mixture was continued for 24 h. The solvent was evaporated and
the residue was dissolved in CH2Cl2 (∼ 50 mL) and washed with distilled
water (2x), dried over Na2SO4 anhydrous, filtered and evaporated (1.27 g,
60%). 1H NMR (CDCl3): δ 1.25 (t, 3H, −CH3), 2.24 (t, 1H), 3.98 (d, 2H,
−CH2C), 4.14 (d, 2H, −CH2C).
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3.3.4 Alkyne functionalization of PEG
Table 3.2 summarizes the reactions carried out to attain this objective.
Figure 3.17: Synthesis reaction of terminal alkyne-functionalized PEG.
General procedure: Dry PEG2000 (4.32 g, 2.16 mmol), 4-pentynoic acid
(0.25 g, 2.55 mmol) and DMAP (0.12 g, 0.98 mmol) were dissolved in 30
mL of distilled CH2Cl2 and the solution was cooled in an ice bath. The
reaction flask was flushed with Ar and DCC (0.59 g, 2.86 mmol) was then
added. The reaction mixture was kept in the ice bath for ∼ 10 min and was
stirred for 15 h at RT under Ar atmosphere. After reaction completion, the
DCC-urea byproduct was filtered off and the solution was precipitated into
cold diethyl ether. The product was then filtered and dried under vacuum
(to obtain a white powder) (2.95 g, 66%). 1H NMR (CDCl3): δ 1.99 (t, 1H,
−C ≡ CH), 2.47-2.54 (m, 2H, −CH2C ≡ CH), 2.56-2.62 (m, 2H, −CH2C),
3.38 (s, 3H, −CH3), 3.54-3.75 (m, 178H, −CH2), 4.26 (t, 2H, −CH2O).
3.3.5 ‘Click’ reaction: PEG-PDMAEMA block copolymer
synthesis attempts
After the synthesis of the alkyne-functionalized PEG, ‘click’ reactions
were carried out in order to assemble a PEG-b-PDMAEMA copolymer. Ta-
ble 3.3 shows the conditions of the reactions performed.
General procedure: In a vial were placed PDMAEMA-azide (653 mg,
0.081 mmol) and DMF (3 mL). A schlenk flask was charged with PEG-
alkyne (204 mg, 0.098 mmol), CuBr (25.7 mg, 0.179 mmol), N,N,N’,N”,N”-
pentamethyl-diethylenetriamine (PMDETA) (31.1 mg, 0.179 mmol) and
DMF (4 mL). DMF was previously bubbled in N2 during 15 min. The
content of the vial was charged into the schlenk flask, deoxygenated with
three freeze-pump-thaw cycles and purged with N2. The reactor was placed
in a pre-heated oil bath at 70 ◦C with stirring (700 rpm) during 48 h. The
copolymer was dialyzed (in distilled water for 3 days) and freeze-dryied.
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Table 3.3: ‘Click’ reactions attempts overview ([PEG-alkyne]/[PDMAEMA-
azide]/[CuBr]/[PMDETA] 1.2/1.0/2.2/2.2 ratio)
Entry Mn(PEG−alkyne)
(g/mol)
Mn(PDMAEMA−azide)
(g/mol)
DMF
(mL)
1 2088.1 7886 8
2 2088.1 12812 7
PDMAEMA synthesis
PDMAEMA was synthetized by LRP:
1. Entry #1
- Initiator: CHO-Br
- Catalytic system: CuBr
- Ligand: PMDETA
- Solvent: THF
- T: 60 ◦C
- t: 4 h
- [DMAEMA]/[CHO-Br]/[CuBr]/[PMDETA]: 45/1/1/1
- [monomer]0/[solvent] (v/v): 1/1
2. Entry #2
- Initiator: EBiB
- Catalytic system: Fe(0)/CuBr2
- Ligand: PMDETA
- Solvents (v/v): isopropanol/H2O (9/1)
- T: 60 ◦C
- t: 48 h
- [DMAEMA]/EBiB]/[Fe(0)]/[CuBr2]/[PMDETA]: 45/1/0.1/1/1
- [monomer]0/[solvent] (v/v): 1/1
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PDMAEMA azidation reaction
General procedure: A schlenk flask was charged with EBiB-PDMAEMA
and DMF (previously bubbled in N2). Sodium azide (NaN3) was then added
to the mixture. The reactor was purged with N2 and placed in a pre-heated
oil bath at 60 ◦C with stirring during 48 h. The polymer was dialyzed and
freeze-dryied.
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4Results Analysis
4.1 Double-stage convergent growth approach
The synthetic route adopted to construct an aliphatic polyester mon-
odendron based on bis-MPA was a double-stage convergent growth ap-
proach, developed by Fre´chet (Figure 2.6)32. This method allow the synthe-
sis of the [G-4] dendron in six steps, reducing the number of synthetic steps
when compared to a strict convergent growth. The synthesis is essentially
straightforward and the aliphatic ester backbone renders dendrons suitable
for biomedical applications.
First, bis-MPA moiety was protected to afford an acetonide group ([1]).
In the next step, the acid group in bis-MPA was protected by a benzyl ester
group by reaction of the potassium salt of bis-MPA with benzyl bromide
([2]). Chemical shifts of 1H NMR spectrum at 5.21 and 7.36 ppm confirm
the presence of the benzyl group. It is selectivity removed, in high yields, by
catalytic hydrogenolysis without affecting the ester bonds of the dendron.
Esterification reactions were performed using DPTS as catalyst and DCC
as the dehydration agent. Despite all the disadvantages of DCC, such as
formation of N-acylurea, steric hindrance and decrease of yields, several
bis-MPA based dendrimers reported have been successfully synthesized in
this fashion. Moreover, purification process by column chromatography (on
silica gel) was necessary after each esterification reaction.
The acetonide groups could be deprotected in the presence of an acidic
Dowex resin, confirmed by the disappearance of two singlets related to the
methyl groups ([5]).
The fourth generation dendron ([6]) was then obtained in a final cou-
pling step between dendrons [4] and [5], according to the general procedure
described previously.
NMR spectra of different dendron generations ([1] to [6]) may be seen in
41
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Figure 4.1: [6] synthesis reaction.
Appendix A. Successful formation of each generation of dendrons was con-
firmed by the peak integration ratio and the results obtained are discussed.
It can be seen that resonances from the methyl groups are well separated
up to the second generation but in the fourth generation become almost
coincident.
Benzyl ester group of compound [6] was then deprotected by hydrogenol-
ysis to give dendron [7], which core can be functionalized with an alkyne
moiety. In this deprotection step, difficulties were encountered to obtain
a significant cleavage. In this way, several attempts were conducted until
optimal conditions were attained (stirring, PH2 = 10 atm, T = 30
◦C, t =
24 h). Higher pressure was tested and it seems that acetonide groups were
affected and degraded.
1H NMR, ATR-FTIR, MALDI-TOF-MS characterization techniques were
applied to assess structural condition of dendron [7].
Figure 4.2 depicts the 1H NMR spectrum of [7] and confirms the success
of this reaction through the disappearance of the resonance signals at 5.16
(−CH2Ar) and 7.35 (ArH) ppm.
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Figure 4.2: 1H NMR spectrum of [7].
Figure 4.3: ATR-FTIR transmittance spectrum of [7].
ATR-FTIR analysis was also performed to assess whether carboxylic acid
was affected. The spectrum obtained (Figure 4.3) reveals the absence of the
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carboxylic group characteristic absorption peak. Thus, MALDI-TOF-MS
analysis of [7] was conducted in order to assess the integrity of the dendron.
Figure 4.4: Enlargement of the MALDI-TOF-MS in the linear mode from
m/z 2000 to 2200 of dendron [7] with theoretical molecular weight of
[M+Na+] = 2103.25 Da.
MALDI-TOF-MS was employed for the determination of molecular weight
of the dendron. The results are in agreement with the calculated values, as
shown in Figure 4.4, corroborating the presence of the carboxylic group,
unlike suggested by FT-IR technique.
Alkyne functionalization of [G-4] dendron
The next step in this work was the alkyne functionalization of the core
of the dendron [7]. For that reason, several attempts for different conditions
(Table 3.1) were conducted and NMR spectra of each reaction performed is
presented in Appendix A.
For entry #1 to #3, it was expected to find acetylene resonances of the
propargylamine around 2.24 and 3.4 ppm and for the three systems tested it
was found that the reactions were incomplete (confirmed by peak integration
and by the absence of the peak at 3.4 ppm).
The low reactivity of propargylamine could be one of the aspects of
failure of these reactions. In this way, a new alkyne terminal (4-pentyn-1-
ol) was tested, using DPTS and DCC as catalysts.
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Figure 4.5: Example of an alkyne functionalization reaction scheme (entry
#5).
Entry #4 NMR spectrum shows a peak at 2.1 ppm that seems to cor-
respond to acetylene group, but with an integration ratio value below the
expected. 1.8 and 3.7 ppm characteristic resonances reveal no noticeable sig-
nals since dendron has predominant signals in this region that may overlap.
Resonance at 2.4 ppm is also absence.
Novel attempts (entry #5 to #7) were performed, in CH2Cl2 and DMF,
using DMAP/DCC or DMAP/EDC as catalysts. Any of the three reactions
reached total completion since only a peak around 2.56 ppm (related to the
signal of −CH2C ≡ CH) is present and resonances at 2.1 (−C ≡ CH) and
3.7 (−CH2−) ppm are absent in the spectra.
In this way, the initial objective of alkyne functionalization of the core
of the dendron wasn’t accomplished.
4.2 Anhydride route
Since the reactions performed according to the previous approach weren’t
unsuccessful, a novel synthetic route to construct aliphatic polyester den-
drons was carried out based on the dendritic generation growth through
anhydride coupling reactions60.This approach has several advantages such
as short reaction time, facile workup, low-temperature esterification and
higher reactivity when compared to the carboxylic acid.
Anhydride synthesis ([A1]) (in high yields) provide easy access to the
alkyne terminal by condensation with the appropriate alcohol. [G-1] dendron
([A2]) was constructed with an acetylene group at the focal point and the
success of the reaction was verified by 1H NMR (which spectrum is presented
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in Appendix B).
Figure 4.6: [A2] synthesis reaction.
Dendritic generation growth up to second generation continued through
the removal of the acetonide group ([A3]) and subsequent acylation with the
anhydride ([A4]).
Figure 4.7: [A3] synthesis reaction.
Figure 4.8: [A4] synthesis reaction.
The resulting [A4] dendron is rendered reactive by deprotection of the
surface methylene groups.
Figure 4.9: [A5] synthesis reaction.
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At this point, a new approach was carried out based on the reaction of
the dendron [4] with the dendron [A5]. With this esterification reaction, a
[G-4] dendron can be designed faster and with less purification steps when
compared to traditional acylation reactions with the anhydride.
Dendron [A6] was characterized by 1H NMR and ATR-FTIR and the results
obtained are presented below.
Figure 4.10: 1H NMR spectrum of [A6].
Unexpectedly, the resonance at 2.48 ppm corresponding to the −C ≡
CH group is absent and a decrease in the integration ratio of the peak at
4.74 ppm related to −CH2C ≡ CH group is verified. Although esterifica-
tion reaction has occurred (since methylene resonances at 1.17, 1.31, 1.37
and 1.42 ppm are depicted), the conditions of operation could be one of the
reasons for the eventually degradation of the alkyne terminal, preventing a
‘click’ reaction. Formation of micellar aggregates could also be a hypothesis
for the non-detection of the alkyne terminal in the NMR spectrum.
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Figure 4.11: ATR-FTIR transmittance spectra of [A4] and [A6].
FT-IR spectrum of [A6] corroborates the previous conclusion due to the
absence of acetylene characteristic absorption peaks around 3200 and 2100
cm−1 (corresponding to the alkyne terminal).
‘2nd generation’ anhydride synthesis
With the same aim of shorten [G-4] dendron synthesis time and purifi-
cation steps (and have knowledge of its high reactivity), we developed for
the first time a ‘second generation’ anhydride, which was characterized by
1H NMR and ATR-FTIR, confirming the success of the reaction.
Figure 4.12: Anhydride synthesis reaction scheme.
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Figure 4.13: 1H NMR spectrum of [D1].
Figure 4.14: ATR-FTIR transmittance spectrum of [D1].
Next, an anhydride coupling reaction between anhydride [D1] and den-
dron [A3] was performed to afford a [G-3] dendron. The acylation reaction
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was carried out according to the procedure described previously, but diffi-
culties were encountered in the purification step. It was necessary to use a
chromatography solvent of relative high polarity of 100% EtOAc to collect
the compound [D2].
Figure 4.15: [D2] synthesis reaction.
Figure 4.16: 1H NMR spectrum of [D2].
1H NMR spectrum of [D2] shows that acylation reaction was successfully
performed but the signal of −CH2C ≡ CH group at 4.74 ppm, exhibits an
integration ratio below the expected, although the acetylene resonance (at
2.45 ppm) wasn’t affected.
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4.3 Alkyne functionalization of [1]
An attempt to functionalize [1] with an alkyne terminal was also carried
out (Figure 4.17).
Figure 4.17: Synthesis reaction scheme.
Figure 4.18: 1H NMR spectrum of [1] alkyne functionalization reaction.
The 1H NMR spectrum express the presence of acetylene resonance at
2.24 ppm but it also shows the absence of the peak referring to −CH2C ≡
CH group (∼ 3.4 ppm). It can also be seen that acetonide group were af-
fected and degraded.
ATR-FTIR spectrum shows an absorption peak around 3100 cm−1 with
lower intensity when compared to compound [1], and a peak around 3300
cm−1.
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Figure 4.19: ATR-FTIR transmittance spectrum of [1] alkyne functionaliza-
tion reaction.
4.4 Alkyne functionalization of PEG
Terminal alkyne functionalization of mono functional PEG (Mn ∼ 2000)
was accomplish, following the general procedure described previously61.
1H NMR and ATR-FTIR spectra of the reactions performed are pre-
sented in Appendix C. After spectra analysis, it is concluded that attempts
(Table 3.2), until entry #6, weren’t successful, although NMR spectrum of
reaction #5 shows resonances at 2.44 and 3.82 ppm that correspond to the
chemical shifts of the alkyne terminal, but with an integration ratio below
the expected.
Figure 4.20: Synthesis reaction scheme of alkyne-functionalized PEG.
Figure 4.21 depicts the NMR spectrum of the alkyne-functionalized PEG.
The appearance of a doublet at 2.51 and 2.59 ppm and a triplet at 1.99 ppm
confirms the presence of the alkyne group in the backbone of the PEG.
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Figure 4.21: 1H NMR spectrum of PEG-alkyne.
Figure 4.22: ATR-FTIR transmittance spectra of PEG and PEG-alkyne.
The appearance of peaks around 1720 and 3200 cm−1, in the FT-IR
spectrum, suggest the presence of a ester bond in the molecule (carbonyl
group) and the alkynyl C-H stretch, respectively.
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‘Click’ chemistry
After the synthesis of the alkyne-functionalized PEG, ‘click’ reactions
were carried out in order to assemble a PEG-b-PDMAEMA copolymer.
Later, it was find out that bromide terminals of PDMAEMA were affected,
preventing an effective ‘click’ reaction.
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Designing dendritic polymers is a challenging combination of organic and
polymer chemistry and there are still problems that must be overcome to effi-
ciently apply them to medical and pharmaceutical fields. From a theoretical
point-of-view, dendrons and dendrimers exhibit attractive properties which
make them ideal carriers for DDS (as previously referred). However, their
synthesis methodology is a laborious multi-step route that present several
problems.
Use of DCC as a neat reagent, which forms urea byproducts in each
esterification reaction. In this way, the only approach to effectively purify
them is through column chromatography processes. This time-consuming
task is controlled by TLC (which sometimes makes it of difficult evaluation),
requires an optimal polarity solvents balance to efficiently remove excess of
reagents and often presents a low final yield.
Several attempts to deprotect selectively the benzyl group of the [G-4]
dendron were performed due to the necessity of fine tuning of the optimal
conditions to perform the catalytic hydrogenolysis.
Several alkyne functionalization reactions of the [G-4] dendron were car-
ried out for different conditions. Different catalysts were tested, firstly,
propargylamine, but due to its low reactivity, other alkyne terminals, such
as 3-butyn-1-ol and 4-pentyn-1-ol, were used, as well as different solvents,
but without success.
Alkyne terminal identification by NMR and FT-IR is also a arduous
task due to the low integration ratio of this group. We also verified that
alkyne terminal was affected during the esterification and acylation reactions
performed.
We can conclude that for higher dendron generations, access to the core
molecule is very difficult, probably, due to the restricted steric accessibility
controlled by the highly branched architecture (sterically hindered surface
difficults addition of new molecules). In this sense, other route (via anhy-
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dride) was carried out, since it is more reactive, and a [G-2] dendron alkyne
functionalized was accomplished in this fashion.
Low reactivity of propiolic acid and propargyl bromide could also influ-
enced the unsuccessful alkyne functionalization reactions of PEG.
5.1 Future work
In the future, new catalytic systems could also be tested to attempt
the alkyne functionalization of the [G-4] dendron and fine tuning of the
optimal conditions to perform esterification and acylation reactions, in order
to avoid acetylene group degradation, could be explored. Dendron growth
via anhydride can be an alternative to the first methodology, as well as,
attempt to functionalize dendrons of lower generations (using 3-butyn-1-ol
instead of propagylamine). Functionalization of the alkyne terminal with a
fluorescent molecule to identify, in a facile way, the success of the reaction
might be also an alternative.
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Appendix A
NMR spectra
A.1 Double-stage convergent growth approach
Figure A.1: 1H NMR spectrum of [1].
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Appendix B
NMR spectra
B.1 Anhydride route
Figure B.1: 1H NMR spectrum of [A1].
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Appendix C
NMR and FT-IR spectra
C.1 Alkyne functionalization of PEG
Figure C.1: 1H NMR spectrum of entry #1.
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C.1 Alkyne functionalization of PEG NMR and FT-IR spectra
Figure C.2: 1H NMR spectrum of entry #2.
Figure C.3: ATR-FTIR transmittance spectra of #1 and #2 PEG2000 alkyne
functionalization attempts.
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